| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 05/10/2007 | US20070105806 Administering to a patient in needs of treatment, prevention or management of neuropathic pain, a therapeutically or prophylactically effective amount of a double-stranded RNA (dsRNA), consists of a sense strand and an antisense strand that are complementary to each other |
| 05/10/2007 | US20070105805 guanidine-rich oligonucleotides to disrupt disease-causing protein aggregates (Huntington's Disease (HD) protein aggregates) |
| 05/10/2007 | US20070105800 Dinucleotides modified by 2'-deoxy-7-deazaguanosine, arabinoguanosine and a glycerol linker;flexibility in the nature of immune response produced; overcoming of species specificities; vaccines; anticarcinogenic agents; autoimmune disorders; asthma;antiallergens ;bactericides; viricides; parasiticides |
| 05/10/2007 | US20070105799 Codon-optimized polynucleotide-based vaccines against Bacillus anthracis infection |
| 05/10/2007 | US20070105797 Antisense inhibition of laminin-8 expression to inhibit human gliomas |
| 05/10/2007 | US20070105795 Gene expression suppression agents |
| 05/10/2007 | US20070105794 Immunotherapy |
| 05/10/2007 | US20070105784 Substituted quinolines for the treatment of cancer |
| 05/10/2007 | US20070105777 For detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells |
| 05/10/2007 | US20070105771 Anti-CD26 antibodies and methods of use thereof |
| 05/10/2007 | US20070105767 Modulation of the interaction of muc1 with muc1 ligands |
| 05/10/2007 | US20070105764 Fusion protein for controlling production of proteins in bioreactor: cellular therapy (somatic gene therapy); antiviral therapies |
| 05/10/2007 | US20070105762 Non-activated polypeptides having a function of tissue regeneration and method for preparing the same |
| 05/10/2007 | US20070105754 Pharmaceutical composition to prevent and treat epithelial wounds, immunomodulating pharmaceutical composition, pharmaceutical composition, insecticide, insecticide composition insecticide use of lectin KM+ to treat cicatrizations, use of lectin KM+ to prepare immunomodulating medicament, use of lectin KM+ to prepare anti-bacterial medicament, use lectin KM+ to prpare anti-viral medicament, use of lectin KM+ to prepare anti-parasite medicament, use of lectin KM+ to prepare anti-fungal medicament, use of lectin KM+ to prepare anti-parasite medicament expression method, DNA vector, recombinant |
| 05/10/2007 | US20070105202 Dna encoding a protein having d-lactate dehydrogenase activity and uses thereof |
| 05/10/2007 | US20070105199 Methods for generating monovalent IgG |
| 05/10/2007 | US20070105198 Genetic engineering; libraries; lung cells; hybrids; process control; controlling activation; antiinflammatory agents; autoimmune diseases; infections; bone disorders; anticancer agents; drug screening |
| 05/10/2007 | US20070105197 Nucleic acid fragments encoding nitrile hydratase and amidase enzymes from Comamonas testosteroni 5-MGAM-4D and recombinant organisms expressing those enzymes useful for the production of amides and acids |
| 05/10/2007 | US20070105196 Modified green fluorescent proteins and methods for using same |
| 05/10/2007 | US20070105195 Entropic bristle domain sequences and their use in recombinant protein production |
| 05/10/2007 | US20070105192 Cyclodextrin affinity purification |
| 05/10/2007 | US20070105191 Capable of inducing chondrocyte proliferation; Chinese Hamster Ovary, an Escheria coli or a yeast host cell with an expression vector |
| 05/10/2007 | US20070105182 modified by substituting negatively charged amino acids with positively charged amino acids on the exterior of the protein making the protein cell permeable; obviates the need for transfections |
| 05/10/2007 | US20070105173 Modified pyrroloquinoline quinone (pqq) dependent glucose dehydrogenase excellent in substrate specificity |
| 05/10/2007 | US20070105172 A gene construct incorporating any two luciferase genes which emit lights with different colors using an identical substrate such that the gene can be stably expressed in mammalian cells; optimize a reporter gene capable of determining or quantifying multiple transcription activities simultaneosly |
| 05/10/2007 | US20070105171 Human Protease Molecules |
| 05/10/2007 | US20070105164 Cancer diagnosis and therapy |
| 05/10/2007 | US20070105162 Monovalent avidin and streptavidin compositions |
| 05/10/2007 | US20070105161 Identifying gamma -secretase inhibitors that exhibit reduced induction of goblet cell metaplasia; detecting mucin-2 induction or mucin-5AC induction in Notch expressing HT29 cells contacted with a compound that inhibits gamma -secretase |
| 05/10/2007 | US20070105159 Identifying compound that modulates signal transduction by measuring its binding and comparing to sugar; G-protein coupled receptor polypeptide |
| 05/10/2007 | US20070105158 Recombined cell system for deorphanizing g protein-coupled receptors |
| 05/10/2007 | US20070105154 Cell lysis composition, methods of use, apparatus, and kit |
| 05/10/2007 | US20070105153 Maternal Antigen That Embryos Require (MATER); Recognizing epitope by detecting binding; indicative of infertility |
| 05/10/2007 | US20070105150 Method for cell surface display of target proteins using fadl of e.coli |
| 05/10/2007 | US20070105144 Method of nucleic acid analysis |
| 05/10/2007 | US20070105143 Novel bHLH type transcription factor genes |
| 05/10/2007 | US20070105139 Fluorescent probe and fluorescence detecting method |
| 05/10/2007 | US20070105137 Determining whether a naturally occurring strain of algae is toxic, comprisingdetermining whether a sample obtained from said strain of algae comprises a nucleic acid encoding a specific polypeptide; harmful algal blooms; shellfish; gene expression |
| 05/10/2007 | US20070105136 Methods for identifying, diagnosing, and predicting survival of lymphomas |
| 05/10/2007 | US20070105131 Sequencing of surface immobilized polymers utilizing microfluorescence detection |
| 05/10/2007 | US20070105123 IRE-1alpha substrates |
| 05/10/2007 | US20070105122 Primers for synthesizing full-length cDNA and their use |
| 05/10/2007 | US20070105117 Method for in vitro evolution of polypeptides |
| 05/10/2007 | US20070105116 Metal complex type nucleic acid |
| 05/10/2007 | US20070105115 Promoter of the human fatp5 gene and uses |
| 05/10/2007 | US20070105112 Laccases, nucleic acids encoding them and methods for making and using them |
| 05/10/2007 | US20070105109 Sirt1 and genetic disorders |
| 05/10/2007 | US20070105108 Polynucleotides capable of target-depedent circularization and topological linkage |
| 05/10/2007 | US20070105106 Methods and reagents for quantitative analysis of Dehalococcoides species |
| 05/10/2007 | US20070105098 Isolation and use of ryanodine receptors |
| 05/10/2007 | US20070105096 Endocrine cell lines and methods of using same |
| 05/10/2007 | US20070105093 Uncoupling of DNA insert propagation and expression of protein for phage display |
| 05/10/2007 | US20070105091 Real time assay for rotavirus |
| 05/10/2007 | US20070105090 Amplification method |
| 05/10/2007 | US20070104737 Recombinant light chains of botulinum neurotoxins and light chain fusion proteins for use in research and clinical therapy |
| 05/10/2007 | US20070104726 Multimeric complexes of antigens and adjuvants |
| 05/10/2007 | US20070104720 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 05/10/2007 | US20070104718 Gene BRCC-1 and diagnostic and therapeutic uses thereof |
| 05/10/2007 | US20070104713 Nogo receptor homologs |
| 05/10/2007 | US20070104712 Treatment of Inflammatory Bowel Disease with IFN-Gamma Inhibitors |
| 05/10/2007 | US20070104708 Compositions, methods, and kits relating to resistin |
| 05/10/2007 | US20070104696 Use of cell lines to produce active therapeutic proteins |
| 05/10/2007 | US20070104686 Vaccines, immunotherapeutics and methods for using the same |
| 05/10/2007 | US20070104685 Synthetic gene encoding human carcinoembryonic antigen and uses thereof |
| 05/10/2007 | US20070104681 Inhibits Interleukin T Cell Inducible Factors (IL-TIF/IL-22)'s effect on cells |
| 05/10/2007 | US20070104680 Antibodies to natural killer stimulatory factor |
| 05/10/2007 | CA2628477A1 Inhibition of autophagy genes in cancer chemotherapy |
| 05/10/2007 | CA2628300A1 Modified sirna molecules and uses thereof |
| 05/10/2007 | CA2627585A1 Rnai inhibition of influenza virus replication |
| 05/10/2007 | CA2623405A1 Methods and composition to generate unique sequence dna probes labeling of dna probes and the use of these probes |
| 05/09/2007 | EP1783216A1 Telomerase-inhibitory ena oligonucleotide |
| 05/09/2007 | EP1783215A1 Angiostatin and method of use for inhibition of angiogenesis |
| 05/09/2007 | EP1781818A2 Methods for diagnosis using anti-cytokine receptor antibodies |
| 05/09/2007 | EP1781816A1 Compositions and methods for releasing nucleic acids from solid phase binding materials |
| 05/09/2007 | EP1781808A1 Methods of using cleavable solid phases for isolating nucleic acids |
| 05/09/2007 | EP1781781A2 Nucleic acid sequences encoding cel ii endonuclease |
| 05/09/2007 | EP1781684A2 A novel chimeric polypeptide and use thereof |
| 05/09/2007 | EP1781680A2 Universal antibody libraries |
| 05/09/2007 | EP1781338A2 Modulation of cytokine signaling regulators and applications for immunotherapy |
| 05/09/2007 | EP1366197B1 Methods and compositions for amplification of rna sequences |
| 05/09/2007 | EP0868535B9 Methods and compositions for determining the sequence of nucleic acid molecules |
| 05/09/2007 | EP0692029B1 Genetically engineered glutaminase and its use in therapy |
| 05/09/2007 | CN1961071A Methods and constructs for expressing polypeptide polymers in eukaryotic cells using alternative splicing |
| 05/09/2007 | CN1961003A Humanized anti-TGF-beta antibodies |
| 05/09/2007 | CN1961000A Hybrid polypeptides with selectable properties |
| 05/09/2007 | CN1960825A Functionalized colloidal metal compositions and methods |
| 05/09/2007 | CN1958797A Nucleotide sequence of lipase of antarctic candida |
| 05/09/2007 | CN1958614A Fusion protein of chemoattracting small peptide and dual specific antibodies |
| 05/09/2007 | CN1314816C Molecular mark of watermelon linked to gene resistant to field pumpkin yellowwatermelon yellow mosaic virus and uses |
| 05/09/2007 | CN1314704C Oligopeptide suppressor of matrix metalloprotease 2 |
| 05/09/2007 | CN1314700C Process for extracting DNA from biological samples |
| 05/09/2007 | CN1314699C Process for producing deoxyribonucleoside by thymus of pig, sheep or chicken duck as raw material |
| 05/09/2007 | CN1314698C Micromolecule interference RNA aiming at middle period factor gene and use thereof |
| 05/08/2007 | USRE39614 Canine IL-4 immunoregulatory proteins and uses thereof |
| 05/08/2007 | US7214859 Brassica pyruvate dehydrogenase kinase gene |
| 05/08/2007 | US7214858 Comprises nucleotide sequences coding trehalose-6-phosphate phosphatase for enhancing water stress tolerance in plants; tissue engineering |
| 05/08/2007 | US7214857 Comprises nucleotide sequences coding maize non-apical meristem protein (ZMNAM) for improving endosperm, kernal size and plant vigor |
| 05/08/2007 | US7214856 Transforming a plant cell with a polynucleotide; polypeptide has kinase activity which induces the expression of stress-responsive transcription factors |
| 05/08/2007 | US7214855 Maize metallothionein 2 promoter and methods of use |
| 05/08/2007 | US7214854 Maize metallothionein promoter |